144 related articles for article (PubMed ID: 6377638)
1. An overview of LHRH and its analogues: clinical uses.
Crowley WF
Ups J Med Sci; 1984; 89(1):3-12. PubMed ID: 6377638
[No Abstract] [Full Text] [Related]
2. Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.
Manasco PK; Pescovitz OH; Hill SC; Jones JM; Barnes KM; Hench KD; Loriaux DL; Cutler GB
J Pediatr; 1989 Jul; 115(1):105-8. PubMed ID: 2661787
[No Abstract] [Full Text] [Related]
3. Central precocious puberty complicating a virilizing adrenal tumor: treatment with a long-acting LHRH analog.
Pescovitz OH; Hench K; Green O; Comite F; Loriaux DL; Cutler GB
J Pediatr; 1985 Apr; 106(4):612-4. PubMed ID: 3884762
[No Abstract] [Full Text] [Related]
4. NIH conference. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs.
Cutler GB; Hoffman AR; Swerdloff RS; Santen RJ; Meldrum DR; Comite F
Ann Intern Med; 1985 May; 102(5):643-57. PubMed ID: 3920942
[TBL] [Abstract][Full Text] [Related]
5. LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia.
Pescovitz OH; Cassorla F; Comite F; Loriaux DL; Cutler GB
Ann N Y Acad Sci; 1985; 458():174-81. PubMed ID: 3911847
[No Abstract] [Full Text] [Related]
6. Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty.
Feuillan PP; Jones JV; Barnes K; Klein KO; Cutler GB
J Endocrinol Invest; 2001 Oct; 24(9):734-6. PubMed ID: 11716160
[No Abstract] [Full Text] [Related]
7. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
[TBL] [Abstract][Full Text] [Related]
8. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
9. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
10. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
[No Abstract] [Full Text] [Related]
11. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
12. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
Oerter KE; Manasco PK; Barnes KM; Jones J; Hill S; Cutler GB
Acta Paediatr Suppl; 1993 Mar; 388():62-8; discussion 69. PubMed ID: 8329833
[No Abstract] [Full Text] [Related]
13. [True precocious puberty in girl. Therapy with LHRH analogs].
Wasikowa R; Iwanicka Z; Pellar J; Hirowska I; Barg E
Kinderarztl Prax; 1990 Jul; 58(7):335-40. PubMed ID: 2145459
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone analogues in the management of precocious puberty.
Spiliotis BE
Ann N Y Acad Sci; 2000; 900():429-34. PubMed ID: 10818433
[No Abstract] [Full Text] [Related]
15. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
[TBL] [Abstract][Full Text] [Related]
16. From the National Institutes of Health.
Wyngaarden JB
JAMA; 1986 Sep; 256(9):1097. PubMed ID: 3525879
[No Abstract] [Full Text] [Related]
17. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
18. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
[TBL] [Abstract][Full Text] [Related]
19. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
20. Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience.
Kauli R; Pertzelan A; Ben-Zeev Z; Lewin RP; Kaufman H; Schally AM; Schally AV; Laron Z
Clin Endocrinol (Oxf); 1984 Apr; 20(4):377-87. PubMed ID: 6232020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
